Provider review
Direct Meds review
The plainest price mechanics on either board, from a company with an FDA warning letter
$399/month for tirzepatide and $297 for semaglutide, stated as billed monthly with no prepay or auto-refill lever we could find — and an FDA warning letter dated 2025-09-09 over how it marketed those same compounded drugs.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Judged only on how it prices, Direct Meds is the most mechanically honest provider on either board. The product pages state one number, describe it as billed every month, and we could find no prepay tier, auto-refill enrollment, membership or promo code doing quiet work underneath it. "No hidden fees" is language that actually matched what we found. Two things complicate that. The prices are high — $399 for tirzepatide is the top of the board among providers with no lever at all. And the company received an FDA warning letter on 2025-09-09 concerning its marketing of compounded semaglutide and tirzepatide, which is a fact a reader should weigh before a clean pricing page reassures them about everything else.
Direct Meds appears on our tirzepatide provider ranking, our semaglutide provider ranking, our weight-loss ranking for women and our weight-loss ranking for men. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want a price with no commitment mechanics attached and will pay a premium for that
- You want a sublingual rather than injectable semaglutide option
- You want the consult bundled into the monthly price
Look elsewhere if
- You are optimising on cost — cheaper leverless options exist on both boards
- A regulatory warning letter about marketing claims would change your decision
- You are relying on the advertised bulk discount, which we could not reproduce
What it actually costs
What they advertise
Tirzepatide: $399/month injectable, $299/month sublingual. Semaglutide: $297/month injectable, $249/month sublingual. All four are published on the portal product pages, stated as billed every month. A "new patient" promo as low as $199 for a first month is referenced in separate marketing material.
What you actually pay, month to month
$399/month for tirzepatide and $297/month for injectable semaglutide, with no prepay or auto-refill requirement found gating either.
The commitment trap
None found on the standard price — this is one of the few rows where the advertised figure and the recurring figure are the same. The caveats run the other way: an advertised bulk discount for 6- and 12-month plans did not change the displayed price when we used the site's own 90-day toggle, and a first-month $199 promo referenced elsewhere could not be confirmed live at checkout. Neither is used in the figures above.
Money you will meet later
- The consult is described as bundled into the price
- An advertised multi-month bulk discount could not be reproduced on the page and is treated as unconfirmed
Checked live on Direct Meds's own site at https://directmeds.com/portal/products/tirzepatide-injection in July 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Direct Meds bundles in, and what it does not.
Clinician consult
Bundled into the monthly price, with no separate consult fee…
found.
Bloodwork / labs
No lab requirement is published as a gate.
Follow-ups and dose changes
Not separately priced from the monthly figure.
Human support
No dietitian or coaching programme is published.
Injection supplies
Not itemised on the product page.
Shipping
Not stated as a separate charge on the pages reviewed.
Pharmacy, labs and oversight
The pharmacy
Not named on the public product pages, and no 503A or 503B designation is published. The company does hold LegitScript certification.
Oversight
Bundled into the monthly price, with no separate consult fee found. Not separately priced from the monthly figure.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
No ship-to state list is published on the pages reviewed.
The honest cons
The part they would rather you skipped
Direct Meds received an FDA warning letter dated 2025-09-09 concerning its marketing of compounded semaglutide and tirzepatide — the exact products this board ranks it for. A clean, lever-free pricing page is a genuine strength and it is why this row does well on our own transparency framing, but pricing honesty and regulatory compliance are different things, and a reader deserves both facts in the same paragraph rather than one on our board and the other on the FDA's website. Separately, the site advertises a bulk discount for 6- and 12-month plans that did not change the price when we used its own 90-day-supply toggle, so at least one advertised saving here is not reproducible on the page advertising it.
- FDA warning letter dated 2025-09-09 over marketing of compounded semaglutide and tirzepatide
- Highest confirmed no-lever price on the tirzepatide board
- An advertised bulk discount did not change the price when the on-page toggle was used
- No dose-tiered pricing published, no compounding facility named, and no state list
None of this is unique to Direct Meds — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.
How it compares
The other providers we rank on our semaglutide provider ranking — the most specific board Direct Meds sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the verdict.
- BHBodybuilding Health+Deepest peptide catalogue here, and the loosest one
- Enhance MDStates a flat-price-at-every-dose policy in writing — and charges the most for it
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Synergy RxPublishes a starting number, and nothing about what it commits you to
- Sprout HealthA $150 markdown the site never explains, and a semaglutide price quoted by the quarter
- Strut HealthInjection or troche, but $119 is the auto-refill price only
- MadeMedPrices are published — but there is no monthly option at all
- yourEraOne drug priced honestly, the other with no price page at all
6 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Direct Meds's own public disclosures when we last checked them, in July 2026. Prices and terms change without notice — confirm on Direct Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.